Development of a measurement kit that can detect only the active form of GLP-2, such as is the case for GLP-1, might deepen our understanding of the relationship between GLP-2 and NAFLD/NASH in humans. This evidence concerns the gene GCG and metabolic dysfunction-associated steatohepatitis.